Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARα null mice

Blood Pressure

Volumn 17, Issue 1, 2008, Pages 55-63

  Obih, Patience ^a   Oyekan, Adebayo ^b  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Blood pressure; PPAR ; Pressure natriuresis; Salt sensitive hypertension; Sodium transport

Indexed keywords

AMILORIDE; FATTY ACID; HYDROCHLOROTHIAZIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SODIUM; SODIUM CHLORIDE; SODIUM CHLORIDE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN; THIAZIDE DIURETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; FATTY ACID OXIDATION; HEART RATE; HIGH SODIUM INTAKE; HYPERTENSION; IN VIVO STUDY; ION TRANSPORT; KIDNEY FUNCTION; KIDNEY MASS; KNOCKOUT MOUSE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MOUSE STRAIN; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; SODIUM EXCRETION; SODIUM LOAD; SODIUM TRANSPORT; STRAIN DIFFERENCE; URINE VOLUME; WILD TYPE;

AMILORIDE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DIURETICS; DRUG RESISTANCE; HYPERTENSION, RENAL; KIDNEY FUNCTION TESTS; MALE; MICE; MICE, KNOCKOUT; NATRIURESIS; ORGAN SIZE; PPAR ALPHA; SODIUM CHLORIDE; SODIUM CHLORIDE, DIETARY; THIAZIDES;

EID: 45949111351     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050701789278     Document Type: Article

References (28)

1. Guan, Y., Zhang, Y., Davis, L. and Breyer, M. D. (1997) Expression of peroxiome proleferator activated receptors in urinary tract of rabbits and humans. Am J Physiol, 273, pp. F1013-F1022.
2. Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M. Torra, I. P. et al. (1998) Activation of human aortic smooth muscle cells is inhibited by PPARα but not by PPARγ activators. Nature, 393, pp. 790-793.
3. Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M. Gonzalez, F. J. et al. (1999) Peroxisome proliferator activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factor NFκB and AP-1. J Biol Chem, 274, pp. 32048-32054.
4. Marx, N., Sukhova, G. K., Collins, T., Libby, P. and Plutzky, J. (1999) PPARα activators inhibit cytokine-induced vascular adhesion molecule-1 expression in human endothelial cells. Circulation, 99, pp. 3125-3131.
5. Beck, F., Plummer, S., Senior, P. V., Byrne, S., Green, S. and Brammar, W. J. (1992) The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat. Proc R Soc Lond B Biol Sci, 247, pp. 83-87.
6. Auboeuf, D., Rieusset, J., Faja, L., Vakkier, P., Frering, V. Riou, J. P. et al. (1997) Tissue distribution and quantification of the expression of mRNAs of peroxisome proleferator activated receptors and liver X receptor-α in humans. No alteration in adipose tissue of obese and NIDDM patients. Diabetes, 46, pp. 1319-1327.
7. Kintscher, U., Lyon, C., Wakino, S., Bruemmer, D., Feng, X. Goetze, S. et al. (2002) PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4. Circ Res, 91, pp. e35-e44.
8. Diep, Q. N., Touyz, R. M. and Schiffrin, E. L. (2000) Docosahexaenoic acid, a peroxisome proliferators activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension, 36, pp. 851-855.
9. Diep, Q. N., Amiri, F., Touyz, R. M., Cohn, J. S., Endemann, D. Neves, M. F. et al. (2002) PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension, 40, pp. 866-871.
10. Diep, Q. N. and Schiffrin, E. L. (2001) Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats. Hypertension, 38, pp. 249-254.
11. Williams, J. M., Zhao, X., Wang, M. H., Imig, J. D. and Pollock, D. M. (2005) Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade. Hypertension, 46, pp. 366-371.
12. Guan, Y. (2004) Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J Am Soc Nephrol, 15, pp. 2801-2815.
13. Alonso-Galicia, M., Frohlich, B. and Roman, R. J. (1998) Induction of P4504A activity improves pressure-natriuresis in Dahl S rats. Hypertension, 31, pp. 232-236.
14. + transport in the rat. BMC Pharmacol, 4, p. 1.
15. Rosskopf, D., Dusing, R. and Siffert, W. (1993) Membrane sodium-proton exchange and primary hypertension. Hypertension, 21, pp. 607-617.
16. Plotkin, M. D., Kaplan, M. R., Verlander, J. W., Lee, W. S., Brown, D. Poch, E. et al. (1996) Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney. Kidney Int, 50, pp. 174-183.
17. Khan, O., Riazi, S., Hu, X., Song, J., Wade, J. B. and Ecelbarger, C. A. (2005) Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone. Am J Physiol Renal Physiol, 289, pp. F442-F450.
18. Song, J., Hu, X., Riazi, S., Tiwari, S., Wade, J. B. and Ecelbarger, C. A. (2006) Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol, 290, pp. F1055-F1064.
19. Li, J. and Wang, D. H. (2005) Function and regulation of epithelial sodium transporters in the kidneys of a salt-sensitive hypertensive rat model. Hypertension, 46, p. P71.
20. Kanie, N., Matsumoto, T., Kobayashi, T. and Kamara, K. (2003) Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats. Br J Pharmacol, 140, pp. 23-32.
21. Tabernero, A., Schoonjans, K., Jesel, L., Carpusca, I., Auwerx, J. and Andriantsitohaina, R. (2002) Activation of the peroxisome proliferator-activated receptor-α protects against myocardial ischaemic injury and improves endothelial vasodilatation. BMC Pharmacol, 2, pp. 10-20.
22. Loichot, C., Jese, L., Tesse, A., Tabernero, A., Schoonjans, K. Roul, G. et al. (2006) Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions. Am J Physiol, 291, pp. H161-H166.
23. Iglarz, M., Touyz, R. M., Viel, E. C., Paradis, P., Amiri, F. Diep, Q. N. et al. (2003) Proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension. Hypertension, 42, pp. 737-743.
24. Newaz, M. A., Blanton, A., Fidelis, P. and Oyekan, A. O. (2005) NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects. Mutat Res, 579, pp. 163-171.
25. Portilla, D., Dai, G., Peters, JM., Gonzalez, F. J., Crew, M. D. and Proia, A. D. (2000) Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol, 278, pp. F667-F675.
26. Portilla, D. (2003) Energy metabolism and cytotoxicity. Semin Nephrol, 23, pp. 432-438.
27. Bunger, M., van den Bosch, H. M., van der Meijde, J., Kersten, S., Hooiveld, G. J. and Muller, M. (2007) Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol Genomics, 30, pp. 192-204.
28. Mazzon, E. and Cuzzocrea, S. (2007) Absence of functional peroxisome proliferator-activated receptor-alpha enhanced ileum permeability during experimental colitis. Shock, 28, pp. 192-201.